Second Degree AV Block - Mobitz II

1. Executive Overview: Understanding Mobitz II AV Block

Second-degree atrioventricular (AV) block, Mobitz type II, is a significant cardiac conduction disorder characterized by the intermittent failure of the AV node to conduct electrical impulses from the atria to the ventricles. Unlike Mobitz type I (Wenckebach phenomenon), which is typically benign and localized to the AV node, Mobitz II is almost exclusively associated with disease located in the His-Purkinje system, distal to the AV node.

Clinically, Mobitz II is defined by a constant PR interval preceding the dropped beat. This indicates that the electrical signal is not progressively delayed but rather abruptly blocked. Because this condition carries a high risk of progression to third-degree (complete) heart block—a life-threatening arrhythmia—it is categorized as a high-grade conduction disturbance requiring urgent cardiological evaluation and, frequently, permanent pacemaker implantation.

2. Pathophysiology, Etiology, and Risk Factors

The Pathophysiology of Conduction Failure

In a healthy heart, the electrical impulse originates in the sinoatrial (SA) node, travels through the atria to the AV node, and proceeds down the Bundle of His into the bundle branches. In Mobitz II, the block occurs within the infra-Hisian system. Because the conduction system distal to the AV node is less reliable than the AV node itself, a failure here is rarely physiological and almost always pathological.

Etiology

The etiology of Mobitz II is rooted in structural damage to the conduction system. Common causes include:
* Idiopathic Fibrosis: Lenègre’s disease or Lev’s disease, which involve the progressive degeneration of the conduction pathways.
* Ischemic Heart Disease: Myocardial infarction, particularly anterior wall MIs that compromise the septal blood supply (LAD artery).
* Post-Surgical Complications: Damage following valve replacement or congenital heart defect repairs.
* Infiltrative Cardiomyopathies: Sarcoidosis, amyloidosis, or hemochromatosis.
* Electrolyte Imbalances: Severe hyperkalemia.
* Pharmacological Toxicity: Excessive use of beta-blockers, calcium channel blockers, or digoxin.

Risk Factors

3. Signs, Symptoms, and Clinical Presentation

Mobitz II block is frequently asymptomatic until the heart rate drops significantly or the block progresses to a 2:1 or 3:1 ratio. When symptoms do manifest, they reflect cerebral or systemic hypoperfusion.

Clinical Signs

• Syncope: Sudden loss of consciousness due to transient asystole.
• Presyncope/Dizziness: Feeling lightheaded or "near-fainting."
• Fatigue: Generalized weakness due to inadequate cardiac output.
• Dyspnea: Shortness of breath, particularly during physical exertion.
• Palpitations: Sensation of an irregular or slow heartbeat.

Physical Examination Findings

During a physical exam, the physician may note an irregular pulse. Auscultation may reveal a "dropped" beat, where the radial pulse is absent despite the presence of an atrial contraction. If the block is high-grade (e.g., 2:1), the patient may present with overt bradycardia.

4. Standard Diagnostic Evaluation & Workup

The diagnosis of Mobitz II is primarily established through electrocardiography (ECG).

Diagnostic Criteria (ECG)

1. PR Interval: The PR interval remains constant for all conducted beats.
2. Dropped Beats: Intermittent non-conducted P waves (P waves not followed by a QRS complex).
3. QRS Morphology: Often wide (bundle branch block pattern), indicating distal conduction disease.

Recommended Workup

• 12-Lead ECG: The gold standard for identifying the block pattern.
• Holter Monitoring (24–48 hours): Used to capture transient episodes in patients with intermittent symptoms.
• Event Recorder: For patients with infrequent symptoms.
• Electrophysiology Study (EPS): An invasive procedure to locate the site of the block (His-Purkinje system) if the diagnosis remains uncertain.
• Laboratory Assays: Troponin levels (to rule out acute MI), serum electrolytes (Potassium, Magnesium), and TSH levels (to rule out hypothyroidism).
• Echocardiography: To evaluate structural heart disease, left ventricular ejection fraction (LVEF), and valvular function.

5. Therapeutic Interventions

The management of Mobitz II is centered on the prevention of sudden cardiac death and the restoration of hemodynamic stability.

Pharmacological Management

There is no "cure" for Mobitz II via medication. In fact, the primary pharmacological intervention is the discontinuation of rate-slowing agents. Any medications that exacerbate AV conduction (Beta-blockers, CCBs, Digoxin) must be reviewed and discontinued if possible. In acute, symptomatic settings, atropine may be used as a temporary bridge, though it is often ineffective in infra-Hisian blocks.

Surgical/Device Intervention

• Permanent Pacemaker (PPM): This is the definitive standard of care. Because Mobitz II is prone to progressing to complete heart block, most international guidelines (ACC/AHA/ESC) recommend a permanent pacemaker for all patients with documented Mobitz II, regardless of symptoms.
• Temporary Pacing: Used in emergency settings (e.g., acute myocardial infarction) to maintain adequate cardiac output while awaiting permanent device placement.

Lifestyle Modifications

While not a treatment for the block itself, patients are advised to:
* Maintain optimal electrolyte balance.
* Monitor heart rate via wearable technology.
* Avoid stimulants that may trigger arrhythmias.
* Follow up regularly with an electrophysiologist.

6. Frequently Asked Questions (FAQ)

1. Is Mobitz II heart block dangerous?

Yes, it is considered a high-risk arrhythmia because it can unpredictably progress to third-degree heart block, which may lead to syncope or cardiac arrest.

2. Can Mobitz II be reversed with medication?

No. Mobitz II is usually caused by structural damage to the electrical system. It cannot be reversed with pills; it requires permanent pacing.

3. What is the difference between Mobitz I and II?

Mobitz I (Wenckebach) involves progressive PR prolongation and is usually benign. Mobitz II has a constant PR interval and is high-risk, requiring a pacemaker.

4. Do I need a pacemaker if I feel fine?

Current clinical guidelines generally recommend a pacemaker for Mobitz II even in asymptomatic patients due to the high risk of sudden progression.

5. How long is the recovery after pacemaker surgery?

Most patients recover within a few days, with full activity resumed within 4–6 weeks. It is a minimally invasive procedure performed under local anesthesia.

6. Can stress cause Mobitz II?

Stress does not cause the underlying structural damage, but it can increase the demand on the heart, potentially exacerbating symptoms if the block is present.

7. What happens if Mobitz II is left untreated?

Left untreated, the heart may stop conducting signals entirely (complete heart block), leading to syncope, falls, or sudden cardiac death.

8. Is this condition hereditary?

While some conduction diseases have a genetic component, most cases of Mobitz II are acquired through aging, fibrosis, or previous heart disease.

9. Can I exercise with a Mobitz II diagnosis?

Until you are cleared by a cardiologist or have received a pacemaker, vigorous exercise is generally discouraged due to the risk of fainting.

10. Will a pacemaker cure my heart block?

A pacemaker will not "fix" your natural electrical system, but it will bypass the block, ensuring your heart maintains a steady, healthy rhythm.

Disclaimer: This guide is for educational purposes only and does not constitute professional medical advice. Always consult with a board-certified cardiologist regarding your specific cardiac health.

Related Clinical Integration

In the management of Second Degree AV Block - Mobitz II, clinical intervention must prioritize hemodynamic stabilization and the prevention of progression to complete heart block. While Atropine / أتروبين 1mg/ml may be considered for transient symptomatic bradycardia, it is often ineffective in Mobitz II due to the block's infra-nodal location; therefore, clinicians should be prepared to administer Epinephrine / إبينفرين 1mg/10ml as a temporizing measure to maintain cardiac output. Given the high risk of sudden progression to third-degree AV block, definitive treatment in a modern hospital setting necessitates the urgent evaluation for a Pacemaker / منظم ضربات القلب (معدات طبية عامة), which serves as the gold-standard therapy to ensure reliable ventricular rhythm and long-term patient safety.